Paolo D’ Ambrosio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paolo D’ Ambrosio has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Andre La Gerche
St Vincent's Institute of Medical Research
8 shared publications Bernard Paelinck
5 shared publicationsDaisy Thijs
5 shared publicationsDominique Hansen
5 shared publicationsDorien Vermeulen
5 shared publicationsGuido Claessen
Department of Cardiology, Hartcentrum, Jessa Hospital, Hasselt, Belgium; Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium; Department of Cardiovascular Diseases, UZ Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium
5 shared publications
Latest Publications
- Open Access
- 23 April 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (9) , 2210-2222
Using Atrial Cardiomyopathy Metrics to Characterize Atrial Fibrillation in Endurance Athletes
- 23 April 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (9) , 2210-2222
Open AccessUsing Atrial Cardiomyopathy Metrics to Characterize Atrial Fibrillation in Endurance Athletes
- Open Access
- 10 March 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (8) , 1454-1464
Exercise blood pressure response does not differentiate endurance athletes with paroxysmal atrial fibrillation
Aims: Atrial fibrillation (AF) is more prevalent among endurance athletes than in the general population. An exaggerated blood pressure (BP) response to exercise may contribute to atrial pressure excess and AF risk. We hypothesized that higher exercise BP would be associated with left atrial enlargement and AF prevalence in endurance athletes. Methods and results: One hundred seventy-eight endurance-trained athletes, 89 with paroxysmal AF [median age 55 (IQR: 46–62 years), 92% male] and 89 age- and sex-matched athletes without AF, underwent resting echocardiography and cardiopulmonary exercise testing with automated BP measurements. Athletes with hypertension were excluded. Absolute BP responses [maximal systolic (SBPmax) and diastolic (DBPmax)] and BP responses relative to exercise workload (W) (SBP/W-slope, DBP/W-slope, and the SBPmax/W-ratio) were compared between groups. Both groups had similar years of training (P = 0.83) and peak oxygen uptake (P = 0.34). Athletes with AF had significantly larger left atrial volumes (LAVi; 48 mL/m2 vs. 42 mL/m2, P < 0.001), higher mean resting SBP (132 ± 13 mmHg vs. 127 ± 14 mmHg, P = 0.018), and DBP (76 ± 10 mmHg vs. 73 ± 11 mmHg, P = 0.090) compared with athletes without AF. There were no differences in SBPmax (221 ± 23 mmHg vs. 219 ± 26 mmHg, P = 0.54) or DBPmax (P = 0.84) in athletes with and without AF, respectively. In athletes with AF, SBP/W-slope was lower, whilst DBP/W-slope and SBPmax/W-ratio were similar to athletes without AF (P = 0.022, P = 0.63, and P = 0.82, respectively). Furthermore, there was no difference in exercise BP responses in those athletes with and without severely dilated LAVi. Conclusion: In endurance athletes, neither AF nor left atrial dilation was associated with higher exercise BP responses.
- 10 March 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (8) , 1454-1464
Open AccessExercise blood pressure response does not differentiate endurance athletes with paroxysmal atrial fibrillation
Aims: Atrial fibrillation (AF) is more prevalent among endurance athletes than in the general population. An exaggerated blood pressure (BP) response to exercise may contribute to atrial pressure excess and AF risk. We hypothesized that higher exercise BP would be associated with left atrial enlargement and AF prevalence in endurance athletes. Methods and results: One hundred seventy-eight endurance-trained athletes, 89 with paroxysmal AF [median age 55 (IQR: 46–62 years), 92% male] and 89 age- and sex-matched athletes without AF, underwent resting echocardiography and cardiopulmonary exercise testing with automated BP measurements. Athletes with hypertension were excluded. Absolute BP responses [maximal systolic (SBPmax) and diastolic (DBPmax)] and BP responses relative to exercise workload (W) (SBP/W-slope, DBP/W-slope, and the SBPmax/W-ratio) were compared between groups. Both groups had similar years of training (P = 0.83) and peak oxygen uptake (P = 0.34). Athletes with AF had significantly larger left atrial volumes (LAVi; 48 mL/m2 vs. 42 mL/m2, P < 0.001), higher mean resting SBP (132 ± 13 mmHg vs. 127 ± 14 mmHg, P = 0.018), and DBP (76 ± 10 mmHg vs. 73 ± 11 mmHg, P = 0.090) compared with athletes without AF. There were no differences in SBPmax (221 ± 23 mmHg vs. 219 ± 26 mmHg, P = 0.54) or DBPmax (P = 0.84) in athletes with and without AF, respectively. In athletes with AF, SBP/W-slope was lower, whilst DBP/W-slope and SBPmax/W-ratio were similar to athletes without AF (P = 0.022, P = 0.63, and P = 0.82, respectively). Furthermore, there was no difference in exercise BP responses in those athletes with and without severely dilated LAVi. Conclusion: In endurance athletes, neither AF nor left atrial dilation was associated with higher exercise BP responses.
- Open Access
- 3 March 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (9) , 616-630
Bradycardia in Athletes: Prevalence, Mechanisms, and Risks
BACKGROUND: Sinus bradycardia is a well-recognized physiological adaptation in endurance athletes, primarily attributed to sinus node remodeling or increased vagal modulation. Although genetic influences on resting heart rate (HR) have been observed, the genetic contribution to athletic bradycardia has not been elucidated. METHODS: We phenotyped current and former elite endurance athletes in the Pro@Heart cohort study using multimodal cardiac imaging, cardiopulmonary exercise testing, and Holter monitoring. Genetic susceptibility to bradycardia was assessed using a validated HR-associated polygenic risk score (HR-PRS), in which lower scores are associated with a lower HR, and compared with healthy nonathletic controls. Clinical and genetic features of bradycardic endurance athletes with minimum HR ≤40 bpm on a Holter monitor (bradycardic athletes [BAs]) were compared with non-BAs). A healthy cohort of nonathletes from the ASPREE study (Aspirin in Reducing Events in the Elderly) were used for genetic comparisons. RESULTS: Among 465 endurance athletes (median age, 23 [18–49] years, 75% men), 175 (38%) had a minimum HR on a Holter monitor ≤40 bpm, of whom 7 (2% of total) had a HR ≤30bpm. Pauses ≥2 s were observed in 115 (25%) athletes, of whom 12 (3% of total) had pauses ≥3 s. Mobitz I second-degree atrioventricular block was observed in 15 (3% of total) athletes. BAs were younger and fitter and exhibited greater athletic cardiac remodeling than non-BAs. Mean HR-PRS was significantly lower in all athletes compared with ASPREE nonathletes ( P P =0.006). When the distribution of HR-PRS within our athletic cohort was considered, athletes with scores in the bottom quartile had a lower minimum HR (median HR, 41 [35–45] bpm versus 45 [40–49] bpm, P P P= 0.004). Neither bradycardia nor pauses were associated with increased risk of adverse outcomes over 5.5 years. CONCLUSIONS: Resting bradycardia (HR ≤40 bpm) and pauses of 2 to 3 s are present in a significant proportion of endurance athletes and are well tolerated. Our data suggest that both fitness and genetic variation contribute to sinus node function in endurance athletes. Intriguingly, HR-PRS differed between athletes and nonathletes, raising the possibility that genetics may be a determinant of athleticism.
- 3 March 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (9) , 616-630
Open AccessBradycardia in Athletes: Prevalence, Mechanisms, and Risks
BACKGROUND: Sinus bradycardia is a well-recognized physiological adaptation in endurance athletes, primarily attributed to sinus node remodeling or increased vagal modulation. Although genetic influences on resting heart rate (HR) have been observed, the genetic contribution to athletic bradycardia has not been elucidated. METHODS: We phenotyped current and former elite endurance athletes in the Pro@Heart cohort study using multimodal cardiac imaging, cardiopulmonary exercise testing, and Holter monitoring. Genetic susceptibility to bradycardia was assessed using a validated HR-associated polygenic risk score (HR-PRS), in which lower scores are associated with a lower HR, and compared with healthy nonathletic controls. Clinical and genetic features of bradycardic endurance athletes with minimum HR ≤40 bpm on a Holter monitor (bradycardic athletes [BAs]) were compared with non-BAs). A healthy cohort of nonathletes from the ASPREE study (Aspirin in Reducing Events in the Elderly) were used for genetic comparisons. RESULTS: Among 465 endurance athletes (median age, 23 [18–49] years, 75% men), 175 (38%) had a minimum HR on a Holter monitor ≤40 bpm, of whom 7 (2% of total) had a HR ≤30bpm. Pauses ≥2 s were observed in 115 (25%) athletes, of whom 12 (3% of total) had pauses ≥3 s. Mobitz I second-degree atrioventricular block was observed in 15 (3% of total) athletes. BAs were younger and fitter and exhibited greater athletic cardiac remodeling than non-BAs. Mean HR-PRS was significantly lower in all athletes compared with ASPREE nonathletes ( P P =0.006). When the distribution of HR-PRS within our athletic cohort was considered, athletes with scores in the bottom quartile had a lower minimum HR (median HR, 41 [35–45] bpm versus 45 [40–49] bpm, P P P= 0.004). Neither bradycardia nor pauses were associated with increased risk of adverse outcomes over 5.5 years. CONCLUSIONS: Resting bradycardia (HR ≤40 bpm) and pauses of 2 to 3 s are present in a significant proportion of endurance athletes and are well tolerated. Our data suggest that both fitness and genetic variation contribute to sinus node function in endurance athletes. Intriguingly, HR-PRS differed between athletes and nonathletes, raising the possibility that genetics may be a determinant of athleticism.
- 18 December 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (8) , 1405-1416
Myocardial fibrosis and its relationship with ventricular arrhythmias and reduced ventricular systolic function in young and veteran endurance athletes
Aims: The prevalence of ventricular fibrosis and its association with ventricular arrhythmias (VAs) and reduced ventricular systolic function in endurance athletes remains unclear. Methods and results: We evaluated 296 young [median age 19 (17–22)] and 138 middle-aged [56 (50–60)] male endurance athletes, alongside 66 middle-aged non-athletic controls [54 (49–60)], all without known cardiac disease. Cardiac magnetic resonance imaging assessed myocardial fibrosis and biventricular function. Twenty-four-hour Holter monitoring was used to quantify VAs. Non-hinge-point fibrosis was more prevalent in middle-aged athletes compared with young athletes (20 vs. 3%, P < 0.001) and middle-aged controls (20 vs. 9%, P = 0.045), while hinge-point fibrosis did not differ. Reduced left ventricular ejection fraction and/or right ventricular ejection fraction was more frequent in middle-aged athletes than controls (23 vs. 8%, P = 0.009), but similar to young athletes (23 vs. 22%, P = 0.906). Middle-aged athletes had a higher prevalence of non-sustained ventricular tachycardia (8 vs. 2%, P = 0.006), >100 premature ventricular complexes/24 h (13 vs. 5%, P = 0.004), multifocal ventricular ectopy (11 vs. 4%, P = 0.003), and complex ventricular ectopy (25 vs. 10%, P < 0.001) compared with young athletes, with no significant differences compared with controls. Non-hinge-point fibrosis increased the odds of a higher burden of unifocal and multifocal ventricular ectopy, but not of reduced systolic function. Conclusion: Middle-aged athletes more frequently exhibit myocardial fibrosis than young athletes and middle-aged non-athletes. Non-hinge-point fibrosis is present in up to one-fifth of middle-aged athletes and predictive of a higher burden of both unifocal and multifocal ventricular ectopy. Reduced systolic function is more prevalent in athletes and not predicted by fibrosis. Lay summary: We studied young and middle-aged male endurance athletes and non-athletes using heart magnetic resonance imaging scans and 24 h heart rhythm monitoring to evaluate scarring of the heart muscle, pumping function, and abnormal heart rhythms.Scarring of the heart muscle is relatively common in middle-aged athletes, but rare in the young. About one in five middle-aged athletes showed a particular ‘non-hinge-point’ pattern of scar tissue, which was rare in young athletes and also less frequent in middle-aged non-athletic individuals.Non-hinge-point scar was linked with more frequent abnormal heart rhythms. Athletes with this pattern of scar more frequently had premature ventricular beats (extra beats originating from the heart’s lower chambers).
- 18 December 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (8) , 1405-1416
Myocardial fibrosis and its relationship with ventricular arrhythmias and reduced ventricular systolic function in young and veteran endurance athletes
Aims: The prevalence of ventricular fibrosis and its association with ventricular arrhythmias (VAs) and reduced ventricular systolic function in endurance athletes remains unclear. Methods and results: We evaluated 296 young [median age 19 (17–22)] and 138 middle-aged [56 (50–60)] male endurance athletes, alongside 66 middle-aged non-athletic controls [54 (49–60)], all without known cardiac disease. Cardiac magnetic resonance imaging assessed myocardial fibrosis and biventricular function. Twenty-four-hour Holter monitoring was used to quantify VAs. Non-hinge-point fibrosis was more prevalent in middle-aged athletes compared with young athletes (20 vs. 3%, P < 0.001) and middle-aged controls (20 vs. 9%, P = 0.045), while hinge-point fibrosis did not differ. Reduced left ventricular ejection fraction and/or right ventricular ejection fraction was more frequent in middle-aged athletes than controls (23 vs. 8%, P = 0.009), but similar to young athletes (23 vs. 22%, P = 0.906). Middle-aged athletes had a higher prevalence of non-sustained ventricular tachycardia (8 vs. 2%, P = 0.006), >100 premature ventricular complexes/24 h (13 vs. 5%, P = 0.004), multifocal ventricular ectopy (11 vs. 4%, P = 0.003), and complex ventricular ectopy (25 vs. 10%, P < 0.001) compared with young athletes, with no significant differences compared with controls. Non-hinge-point fibrosis increased the odds of a higher burden of unifocal and multifocal ventricular ectopy, but not of reduced systolic function. Conclusion: Middle-aged athletes more frequently exhibit myocardial fibrosis than young athletes and middle-aged non-athletes. Non-hinge-point fibrosis is present in up to one-fifth of middle-aged athletes and predictive of a higher burden of both unifocal and multifocal ventricular ectopy. Reduced systolic function is more prevalent in athletes and not predicted by fibrosis. Lay summary: We studied young and middle-aged male endurance athletes and non-athletes using heart magnetic resonance imaging scans and 24 h heart rhythm monitoring to evaluate scarring of the heart muscle, pumping function, and abnormal heart rhythms.Scarring of the heart muscle is relatively common in middle-aged athletes, but rare in the young. About one in five middle-aged athletes showed a particular ‘non-hinge-point’ pattern of scar tissue, which was rare in young athletes and also less frequent in middle-aged non-athletic individuals.Non-hinge-point scar was linked with more frequent abnormal heart rhythms. Athletes with this pattern of scar more frequently had premature ventricular beats (extra beats originating from the heart’s lower chambers).
- 22 October 2025
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 40 (1) , 10-17
Diagnostic accuracy of different exercise blood pressure metrics in identifying hypertension on 24-h ambulatory blood pressure monitoring in athletes
Exercise blood pressure (BP) metrics have been promoted as a means of identifying latent or mild hypertension in athletes. We evaluated the diagnostic accuracy of four exercise BP metrics to diagnose hypertension, defined by 24-h ambulatory BP monitoring (ABPM) as mean ≥130/80 mmHg, daytime ≥135/85 mmHg and/or nighttime ≥120/70 mmHg. Fifty-four endurance-trained athletes (48 [IQR 24–58] years, 67% male) underwent exercise testing with serial BP measurements and 24-h ABPM. Exaggerated exercise BP (EEBP) was defined as exceeding a threshold for any of the four metrics: 1) maximal systolic BP (SBPmax) using published cut-offs; SBPmax ≥ 220 mmHg and ≥200 mmHg in males and females, respectively, 2) SBP/Workload-slope, 3) SBPmax/Workload-ratio, 4) SBP at 2 Watts/kg. Receiver operating characteristic (ROC) curve analysis and Youden’s Index determined optimal cut-offs and diagnostic performance. Twelve of 54 (22%) athletes met criteria for hypertension. SBPmax was reasonably sensitive for identifying hypertension (83% identified) but demonstrated poor specificity (62% of non-hypertensives misclassified), with an area under the ROC-curve (AUC) of 0.63. An EEBP cut-off of SBP > 176 mmHg at 2 Watts/kg had the best diagnostic performance with 100% sensitivity, moderate specificity of 62%, and AUC of 0.79. Other metrics, incorporating exercise BP and workload, SBPmax/Workload-ratio and SBP/Workload-slope, had moderate diagnostic utility (AUC = 0.71 and 0.67, respectively). In endurance athletes, exercise BP metrics demonstrated modest and variable diagnostic accuracy for identifying hypertension on 24-h ABPM. Assessment of SBP at a relative submaximal workload provided acceptable diagnostic accuracy while reducing overdiagnosis associated with published SBPmax thresholds. Graphical Abstract – Created in BioRender. La Gerche, A. (2025) https://BioRender.com/undefined Abbreviations: SBP, systolic blood pressure; ABPM, ambulatory blood pressure monitoring.
- 22 October 2025
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 40 (1) , 10-17
Diagnostic accuracy of different exercise blood pressure metrics in identifying hypertension on 24-h ambulatory blood pressure monitoring in athletes
Exercise blood pressure (BP) metrics have been promoted as a means of identifying latent or mild hypertension in athletes. We evaluated the diagnostic accuracy of four exercise BP metrics to diagnose hypertension, defined by 24-h ambulatory BP monitoring (ABPM) as mean ≥130/80 mmHg, daytime ≥135/85 mmHg and/or nighttime ≥120/70 mmHg. Fifty-four endurance-trained athletes (48 [IQR 24–58] years, 67% male) underwent exercise testing with serial BP measurements and 24-h ABPM. Exaggerated exercise BP (EEBP) was defined as exceeding a threshold for any of the four metrics: 1) maximal systolic BP (SBPmax) using published cut-offs; SBPmax ≥ 220 mmHg and ≥200 mmHg in males and females, respectively, 2) SBP/Workload-slope, 3) SBPmax/Workload-ratio, 4) SBP at 2 Watts/kg. Receiver operating characteristic (ROC) curve analysis and Youden’s Index determined optimal cut-offs and diagnostic performance. Twelve of 54 (22%) athletes met criteria for hypertension. SBPmax was reasonably sensitive for identifying hypertension (83% identified) but demonstrated poor specificity (62% of non-hypertensives misclassified), with an area under the ROC-curve (AUC) of 0.63. An EEBP cut-off of SBP > 176 mmHg at 2 Watts/kg had the best diagnostic performance with 100% sensitivity, moderate specificity of 62%, and AUC of 0.79. Other metrics, incorporating exercise BP and workload, SBPmax/Workload-ratio and SBP/Workload-slope, had moderate diagnostic utility (AUC = 0.71 and 0.67, respectively). In endurance athletes, exercise BP metrics demonstrated modest and variable diagnostic accuracy for identifying hypertension on 24-h ABPM. Assessment of SBP at a relative submaximal workload provided acceptable diagnostic accuracy while reducing overdiagnosis associated with published SBPmax thresholds. Graphical Abstract – Created in BioRender. La Gerche, A. (2025) https://BioRender.com/undefined Abbreviations: SBP, systolic blood pressure; ABPM, ambulatory blood pressure monitoring.
- Open Access
- 11 September 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (10) , 102140
Balancing Exercise Benefits Against Heartbeat Consumption in Elite Cyclists
- 11 September 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (10) , 102140
Open AccessBalancing Exercise Benefits Against Heartbeat Consumption in Elite Cyclists
- 23 July 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (10) , 2225-2237
Mechanistic Insights Into Reduced Arrhythmia Prevalence in Female Endurance Athletes
- 23 July 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (10) , 2225-2237
Mechanistic Insights Into Reduced Arrhythmia Prevalence in Female Endurance Athletes
- Open Access
- 25 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (47) , 5114-5125
Atrial fibrillation in former world-class rowers: role of environmental and genetic factors
Background and Aims: Endurance sport has been associated with an increased risk of atrial fibrillation (AF). The aim of this study was to assess the extent to which this is due to exercise burden or genetic predisposition. Methods: Former rowers aged 45–80 years who competed at international championships were compared with a control group extracted from the UK Biobank, matched (1:100) for age and sex. Evaluation included 12-lead and Holter electrocardiograms, cardiac magnetic resonance imaging, and genetic analyses including rare variant evaluation and derivation of a validated AF polygenic risk score (AF-PRS). Results: Of 121 rowers [age 62 years (interquartile range 54–69), 74% male], 26 (21.5%) had AF as compared with 364 of 11 495 control subjects (3.2%), prevalence risk ratio 6.8 [95% confidence interval (CI) 4.7–9.8]. Incident AF over 4-year follow-up was also greater [6 of 95 rowers (6.3%) vs 252 of 11 131 controls (2.3%), hazard ratio 2.8 (95% CI 1.6–5.0)]. Compared with controls, athletes demonstrated greater structural and electrophysiological cardiac remodelling. Athletes had similar cardiovascular risk factor profiles but a higher stroke prevalence than controls [3.3% vs 1.1%, risk ratio 3.0 (95% CI 1.1–7.9)]. Rare pathogenic and likely pathogenic variants in cardiomyopathy genes had low prevalence in athletes (2.7%) and were not enriched in those with AF. In contrast, in those subjects with a high AF-PRS (defined by the upper quartile in a healthy reference population) the odds of having AF increased 3.7-fold in athletes (95% CI 1.5–9.4) and 2.0-fold in controls (95% CI 1.7–2.4; P = .37 for between-group comparisons). Conclusions: Despite having a favourable cardiovascular risk factor profile compared with controls, elite endurance athletes had a markedly higher prevalence and incidence of AF. These data suggest that exercise-induced cardiac remodelling and genetic susceptibility contribute to AF in endurance athletes.
- 25 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (47) , 5114-5125
Open AccessAtrial fibrillation in former world-class rowers: role of environmental and genetic factors
Background and Aims: Endurance sport has been associated with an increased risk of atrial fibrillation (AF). The aim of this study was to assess the extent to which this is due to exercise burden or genetic predisposition. Methods: Former rowers aged 45–80 years who competed at international championships were compared with a control group extracted from the UK Biobank, matched (1:100) for age and sex. Evaluation included 12-lead and Holter electrocardiograms, cardiac magnetic resonance imaging, and genetic analyses including rare variant evaluation and derivation of a validated AF polygenic risk score (AF-PRS). Results: Of 121 rowers [age 62 years (interquartile range 54–69), 74% male], 26 (21.5%) had AF as compared with 364 of 11 495 control subjects (3.2%), prevalence risk ratio 6.8 [95% confidence interval (CI) 4.7–9.8]. Incident AF over 4-year follow-up was also greater [6 of 95 rowers (6.3%) vs 252 of 11 131 controls (2.3%), hazard ratio 2.8 (95% CI 1.6–5.0)]. Compared with controls, athletes demonstrated greater structural and electrophysiological cardiac remodelling. Athletes had similar cardiovascular risk factor profiles but a higher stroke prevalence than controls [3.3% vs 1.1%, risk ratio 3.0 (95% CI 1.1–7.9)]. Rare pathogenic and likely pathogenic variants in cardiomyopathy genes had low prevalence in athletes (2.7%) and were not enriched in those with AF. In contrast, in those subjects with a high AF-PRS (defined by the upper quartile in a healthy reference population) the odds of having AF increased 3.7-fold in athletes (95% CI 1.5–9.4) and 2.0-fold in controls (95% CI 1.7–2.4; P = .37 for between-group comparisons). Conclusions: Despite having a favourable cardiovascular risk factor profile compared with controls, elite endurance athletes had a markedly higher prevalence and incidence of AF. These data suggest that exercise-induced cardiac remodelling and genetic susceptibility contribute to AF in endurance athletes.
- Open Access
- 5 November 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (12)
Ventricular arrhythmias in association with athletic cardiac remodelling
Athletes are predisposed to atrial arrhythmias but the association between intense endurance exercise training, ventricular arrhythmias (VAs), and sudden cardiac death is less well established. Thus, it is unclear whether the ‘athlete’s heart’ promotes specific arrhythmias or whether it represents a more general pro-arrhythmogenic phenotype. Whilst direct causality has not been established, it appears possible that repeated exposure to high-intensity endurance exercise in some athletes contributes to formation of pro-arrhythmic cardiac phenotypes that underlie VAs. Theories regarding potential mechanisms for exercise-induced VAs include repeated bouts of myocardial inflammation and stretch-induced cellular remodelling. Small animal models provide some insights, but larger animal and human data are sparse. The current clinical approach to VAs in athletes is to differentiate those with and without structural or electrical heart disease. However, if the athlete’s heart involves a degree of pro-arrhythmogenic remodelling, then this may not be such a simple dichotomy. Questions are posed by athletes with VAs in combination with extreme remodelling. Some markers, such as scar on magnetic resonance imaging, may point towards a less benign phenotype but are also quite common in ostensibly healthy athletes. Other clinical and invasive electrophysiology features may be helpful in identifying the at-risk athlete. This review seeks to discuss the association between athletic training and VAs. We will discuss the potential mechanisms, clinical significance, and approach to the management of athletes with VAs.
- 5 November 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (12)
Open AccessVentricular arrhythmias in association with athletic cardiac remodelling
Athletes are predisposed to atrial arrhythmias but the association between intense endurance exercise training, ventricular arrhythmias (VAs), and sudden cardiac death is less well established. Thus, it is unclear whether the ‘athlete’s heart’ promotes specific arrhythmias or whether it represents a more general pro-arrhythmogenic phenotype. Whilst direct causality has not been established, it appears possible that repeated exposure to high-intensity endurance exercise in some athletes contributes to formation of pro-arrhythmic cardiac phenotypes that underlie VAs. Theories regarding potential mechanisms for exercise-induced VAs include repeated bouts of myocardial inflammation and stretch-induced cellular remodelling. Small animal models provide some insights, but larger animal and human data are sparse. The current clinical approach to VAs in athletes is to differentiate those with and without structural or electrical heart disease. However, if the athlete’s heart involves a degree of pro-arrhythmogenic remodelling, then this may not be such a simple dichotomy. Questions are posed by athletes with VAs in combination with extreme remodelling. Some markers, such as scar on magnetic resonance imaging, may point towards a less benign phenotype but are also quite common in ostensibly healthy athletes. Other clinical and invasive electrophysiology features may be helpful in identifying the at-risk athlete. This review seeks to discuss the association between athletic training and VAs. We will discuss the potential mechanisms, clinical significance, and approach to the management of athletes with VAs.
- 20 August 2019
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 14 (6) , 987-995
Prevalence and risk factors for low bone density in adults with a Fontan circulation
Objective and Patients This study aimed to characterize bone mineral density abnormalities and pathophysiological associations in young adults living with a Fontan circulation. Design Participants underwent bone mineral density measurement using dual‐energy X‐ray absorptiometry and serum biochemical analysis, cardiopulmonary exercise and strength testing and transthoracic echocardiography. Results In our cohort (n = 28), 29% had osteopenic‐range bone mineral density and one patient was osteoporotic (average hip t score: −0.6 ± 1.1; spine t score: −0.6 ± 0.9). Four patients (14%) had z scores < −2.0. Parathyroid hormone levels were increased compared with laboratory median (6.1 ± 3.5 vs 4 pmol/L, P = .01) and 27% had 25‐hydroxy‐vitamin D < 50 nmol/L. 25‐hydroxy‐vitamin D negatively correlated with parathyroid hormone (ρ = −0.53, P = .01) suggesting secondary hyperparathyroidism. Atrioventricular valve systolic to diastolic duration ratio, an echocardiographic measure of diastolic dysfunction, inversely correlated with hip t and z scores (P < .01). Hip t scores were positively associated with oxygen saturations (ρ = 0.45, P = .05) and tended to be inversely associated with parathyroid hormone levels (ρ = −0.44, P = .07) and N‐Terminal pro b‐type natriuretic peptide (ρ = −0.42, P = .08). Conclusions Many young adults with a Fontan circulation have abnormal bone mineral density. The underlying pathophysiology is likely multifactorial. Possible contributors include secondary hyperparathyroidism, hypoxemia, diastolic cardiac dysfunction and neurohormonal activation. As low bone mineral density is clinically relevant and potentially treatable, assessment of bone mineral density should be part of routine care in this cohort.
- 20 August 2019
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 14 (6) , 987-995
Prevalence and risk factors for low bone density in adults with a Fontan circulation
Objective and Patients This study aimed to characterize bone mineral density abnormalities and pathophysiological associations in young adults living with a Fontan circulation. Design Participants underwent bone mineral density measurement using dual‐energy X‐ray absorptiometry and serum biochemical analysis, cardiopulmonary exercise and strength testing and transthoracic echocardiography. Results In our cohort (n = 28), 29% had osteopenic‐range bone mineral density and one patient was osteoporotic (average hip t score: −0.6 ± 1.1; spine t score: −0.6 ± 0.9). Four patients (14%) had z scores < −2.0. Parathyroid hormone levels were increased compared with laboratory median (6.1 ± 3.5 vs 4 pmol/L, P = .01) and 27% had 25‐hydroxy‐vitamin D < 50 nmol/L. 25‐hydroxy‐vitamin D negatively correlated with parathyroid hormone (ρ = −0.53, P = .01) suggesting secondary hyperparathyroidism. Atrioventricular valve systolic to diastolic duration ratio, an echocardiographic measure of diastolic dysfunction, inversely correlated with hip t and z scores (P < .01). Hip t scores were positively associated with oxygen saturations (ρ = 0.45, P = .05) and tended to be inversely associated with parathyroid hormone levels (ρ = −0.44, P = .07) and N‐Terminal pro b‐type natriuretic peptide (ρ = −0.42, P = .08). Conclusions Many young adults with a Fontan circulation have abnormal bone mineral density. The underlying pathophysiology is likely multifactorial. Possible contributors include secondary hyperparathyroidism, hypoxemia, diastolic cardiac dysfunction and neurohormonal activation. As low bone mineral density is clinically relevant and potentially treatable, assessment of bone mineral density should be part of routine care in this cohort.